BAP:NYSECredicorp Ltd. Analysis
Data as of 2026-05-19 - not real-time
$303.86
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Credicorp Ltd. (BAP) is trading just above its technical support at $300, with the RSI at 38 indicating near‑oversold conditions and a bearish MACD histogram confirming short‑term pressure. Volume is increasing, suggesting buying interest may be building as the price hovers around the $303.86 level. The stock’s trailing PE of 12.2 is well below the industry average of 16.7, while the forward PE of 9.3 signals further undervaluation. Revenue growth of 21.8% and robust operating margins (≈50%) underpin a strong earnings outlook, reflected in a forward EPS of 32.54. The dividend yield of 4.69% with a 45% payout ratio is supported by a hefty cash pile of $56.9 bn against moderate debt, indicating sustainability.
Target prices from analysts average $360, implying an upside of roughly 18% from current levels, and the company’s strategic focus on digital banking and loan quality could accelerate growth. While 30‑day volatility is high at >50% and beta near 1, the overall risk profile remains moderate, making a buy stance attractive across short, medium, and long horizons.
Target prices from analysts average $360, implying an upside of roughly 18% from current levels, and the company’s strategic focus on digital banking and loan quality could accelerate growth. While 30‑day volatility is high at >50% and beta near 1, the overall risk profile remains moderate, making a buy stance attractive across short, medium, and long horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Price near technical support with rising volume
- Attractive dividend yield and sustainable payout
- Undervalued PE relative to peers
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth exceeding 20% and strong operating margins
- Analyst target price implying ~18% upside
- Low forward PE indicating value upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strategic digital banking initiatives driving future earnings
- Robust cash position and manageable debt
- Sustainable high dividend supporting total return
Key Metrics & Analysis
Financial Health
Revenue Growth21.80%
Profit Margin33.68%
P/E Ratio12.2
ROE19.15%
ROA2.77%
P/B Ratio2.1
Industry P/E16.7
Technical Analysis
TrendNeutral
RSI38.2
Support$300.00
Resistance$345.73
MA 20$322.43
MA 50$330.26
MA 200$295.52
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61
Valuation
Target Price$360.57
Upside/Downside18.66%
GradeUndervalued
TypeGrowth
Dividend Yield4.69%
Risk Assessment
Beta0.95
Volatility52.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.